Tyverb
E2190191
UNEXPLORED
Tyverb is the brand name of lapatinib, an oral targeted cancer therapy used primarily to treat HER2-positive breast cancer.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Tyverb canonical | 1 |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.